List of Excipients in API talazoparib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing talazoparib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Pfizer Laboratories Div Pfizer Inc | TALZENNA | talazoparib | 0069-0252 | .ALPHA.-TOCOPHEROL | 2031-10-20 |
Pfizer Laboratories Div Pfizer Inc | TALZENNA | talazoparib | 0069-0252 | FERRIC OXIDE RED | 2031-10-20 |
Pfizer Laboratories Div Pfizer Inc | TALZENNA | talazoparib | 0069-0252 | GELATIN TYPE A PORCINE | 2031-10-20 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for talazoparib
Excipient focus: .ALPHA.-TOCOPHEROL
talazoparib drug variants containing .ALPHA.-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing .ALPHA.-TOCOPHEROL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
talazoparib drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
talazoparib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
talazoparib drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
talazoparib drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
talazoparib drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN TYPE A PORCINE
talazoparib drug variants containing GELATIN TYPE A PORCINE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing GELATIN TYPE A PORCINE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
talazoparib drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
talazoparib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
talazoparib drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
talazoparib drug variants containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
talazoparib drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
talazoparib drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
talazoparib drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
talazoparib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
talazoparib drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0252 |
>Company | >Ingredient | >NDC |
talazoparib drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | talazoparib | 0069-0296 |
US Pharmaceuticals | talazoparib | 63539-295 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.